Steven M Wishnies

Title: Innovator Spotlight: Steven M. Wishnies and His Contributions to Biomolecule Identification

Introduction: Steven M. Wishnies is a noteworthy inventor based in Columbia, Maryland, recognized for his innovative contributions to the field of biomolecule identification. His work primarily focuses on the application of mass spectrometry techniques to enhance the analysis of biological molecules in tissue samples.

Latest Patents: Steven holds a patent for "Methods for direct biomolecule identification by matrix-assisted laser desorption ionization (MALDI) mass spectrometry." This invention introduces a novel approach that utilizes post-source decay (PSD) or collision-induced dissociation (CID) direct tissue MALDI-TOF for the identification of proteins without the need for earlier protein extraction. The method facilitates the study of cells or tissues through direct tissue MALDI, allowing for in situ protein release and subsequent identification via mass spectrometry and bioinformatics tools like Mascot software.

Career Highlights: Steven M. Wishnies is currently affiliated with New York University, where he continues to advance the field of mass spectrometry. His research aims to improve the understanding of biological processes through enhanced biomolecule identification techniques.

Collaborations: Throughout his career, Steven has collaborated with notable professionals in his field, including Paul H. Pevsner and Frederick Naftolin. These partnerships have contributed to the development and refinement of his innovative methods.

Conclusion: Steven M. Wishnies exemplifies the spirit of innovation in the scientific community. His patent for direct biomolecule identification has the potential to significantly impact biomedical research and clinical applications, paving the way for more efficient and accurate analysis of biomolecular compositions in various biological samples.